Clinique Saint-Pierre Ottignies (CSPO)

At Clinique Saint-Pierre Ottignies, a large share of research focuses on cancer and blood disorders, with studies in breast cancer, prostate cancer, lung cancer, multiple myeloma, lymphoma, and leukemia. These trials are mainly designed to test new treatment combinations, improve disease control, and compare emerging therapies with current standards.

• Breast cancer, including hormone receptor-positive, HER2-negative, HER2-low, and triple-negative disease
• Prostate cancer, including metastatic castration-resistant and castration-sensitive forms
• Hematologic cancers such as multiple myeloma, chronic lymphocytic leukemia, and non-Hodgkin lymphoma
• Lung cancer and other solid tumors, with an emphasis on treatment effectiveness

The site’s oncology portfolio reflects a strong interest in both targeted and immune-based approaches, alongside studies aimed at improving outcomes for patients with advanced or difficult-to-treat disease.

Research in respiratory medicine and intensive care is especially prominent at this health care site, where trials examine pneumonia, acute respiratory distress syndrome, viral lung infection, COVID-19, and sepsis. The main goal is to evaluate new supportive treatments and better strategies for severely ill hospitalized patients.

• Severe community-acquired pneumonia and hospital-acquired pneumonia
• Acute respiratory distress syndrome and other serious lung infections
• Viral pneumonia, including COVID-19-related disease
• Sepsis and sepsis-associated organ injury

These studies often aim to reduce complications, improve recovery, and lower the risk of death in critically ill patients treated in intensive care settings.

Another important research area involves cardiovascular disease and neurology, with trials in cardiac arrest, stroke, and post-anoxic brain injury. The research is centered on evaluating therapies that may protect the brain, support recovery, and improve outcomes after life-threatening events.

• Acute ischemic stroke and related recovery-focused care
• Cardiac arrest and comatose survivors
• Post-cardiac arrest syndrome and brain injury prevention
• Seizure control after resuscitation-related brain injury

At CSPO, this work highlights a commitment to improving urgent care for patients with sudden neurological or cardiac emergencies.

Trials in bacterial infections and mycoses explore better ways to treat serious infections in hospitalized patients, including community-acquired pneumonia, bloodstream infection, and intra-abdominal infection. The purpose is to assess new anti-infective strategies, refine treatment duration, and improve clinical recovery.

• Severe bacterial pneumonia and other serious respiratory infections
• Bloodstream and intra-abdominal infections in critically ill patients
• Hospital infection management and antimicrobial stewardship
• Infection-related complications such as sepsis and organ dysfunction

These studies support the search for safer, more effective infection care in high-risk hospital settings.

Research also spans female urogenital diseases and pregnancy-related complications, with additional attention to human papillomavirus and women’s health in oncology. The trials in this area are aimed at improving prevention, clearance of infection, and treatment decisions for women with complex conditions.

• Genital HPV infection and prevention of persistent infection
• Breast cancer in premenopausal and postmenopausal women
• Pregnancy-related and female urogenital health concerns
• Personalized treatment approaches in hormone-sensitive disease

This work combines preventive research with treatment-focused studies that may help refine care for women across different stages of disease.

Some studies at the site do not fit neatly into a single therapeutic category, reflecting a broader clinical research portfolio. These trials often address complex hospital-based problems and are designed to test new approaches that may improve overall patient outcomes.

• Mixed inpatient conditions requiring intensive monitoring
• Supportive care strategies in severe illness
• Broad evaluations of treatment benefit and safety
• Research aimed at improving recovery in diverse patient groups

The range of topics shows that Clinique Saint-Pierre Ottignies contributes to both highly specialized and cross-cutting clinical research in Europe.